Back to Rafferty Asset Management, LLC Rafferty Asset Management, LLC

XERSXERS
14 quarters

Position history for Rafferty Asset Management, LLCRafferty Asset Management, LLC's holdings in XERIS BIOPHARMA HOLDINGS INC

Rafferty Asset Management, LLC holds 22,889 shares of XERS (XERIS BIOPHARMA HOLDINGS INC), worth $181,281 as of 2026-Q2. The position was decreased (-5.6% shares). XERS represents 0.0% of Rafferty Asset Management, LLC's portfolio.

Current Value

$181,281

Current Shares

22,889

Total Value Change

+$54,281

Total Shares Change

-20,452

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
22,889
-5.6%
$181,2810.0%$7.92
0
2026-Q1
Decreased
24,247
-28.0%
$140,6330.0%$5.94
0
2025-Q4
Increased
33,689
+93.5%
$264,4590.0%$7.31
37
2025-Q3
Decreased
17,411
-32.8%
$141,7260.0%$8.08
0
2025-Q2
Increased
25,903
+72.7%
$120,9670.0%$4.70
33
2025-Q1
Decreased
15,003
-15.3%
$82,3660.0%$5.58
0
2024-Q4
Decreased
17,720
-7.3%
$60,0710.0%$3.38
0
2024-Q3
Decreased
19,112
-2.2%
$54,4690.0%$2.87
0
2024-Q2
Decreased
19,536
-7.9%
$43,9560.0%$2.25
0
2024-Q1
New
21,213
-
$46,8810.0%$2.21
28
2022-Q3
Exited
0
-100.0%
$00.0%$1.59
0
2022-Q2
Increased
35,248
+13.2%
$54,0000.0%$1.48
23
2022-Q1
Decreased
31,143
-28.1%
$80,0000.0%$2.63
0
2021-Q4
New
43,341
-
$127,0000.0%$2.43
31

Other major holders of XERS: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used